Top Banner
Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader
39

Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Feb 25, 2016

Download

Documents

ANIA

Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin. L. E. Kirsch Stability team leader. Stability Team. Linking manufacturing to stability. Manufacturing Stress . API*. (Unstable form). Physical transformation. Chemical transformation. API. Degradant. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Linking Drug Stability to ManufacturingPhysical Chemical Foundations

Gabapentin

L. E. KirschStability team leader

Page 2: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Stability TeamGroup Team member

Minnesota Raj Suryanarayanan (Co-PI)

Aditya Kaushal (post-doc)

Kansas Eric Munson (Co-PI)

Dewey Barich (post-doc)

Elodie Dempah, Eric Gorman (grad. students)

Iowa Lee Kirsch (Co-PI)

Greg Huang (Analytical Chemist)

Salil Desai, Zhixin Zong, Tinmanee Radaduen, Hoa Nguyen, Jiang Qiu (grad students)

Duquesne(Unit-op team Interface)

Ira Buckner

Page 3: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

3

Linking manufacturing to stability

API

API*

Degradant

PHYSICAL

TRANSFORMATION Chemica

l

trans

form

ation

(Stable form)

(Unstable form)

Page 4: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

4

Gabapentin as a model drug substance

NH2

OH

O

gabapentin(Gaba)

• Multiple crystalline forms• Susceptible to stress-induced physical

transformations• Susceptible to chemical degradation

NH3+

O-

O

NH2

O-

O

NH3+

OH

O

pKa 3.7 pKa 10

KEY QUESTIONS1. Are physical and chemical instability

linked?2. How can manufacturing-induced stress be

incorporated in a quantitative chemical instability model?

Page 5: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Some Crystalline Forms of Gabapentin

5

API form Crystalline

I

II

III

IV

Ibers., Acta Cryst c57, 2001 and Reece and Levendis., Acta Cryst. c64 2008

Transition between forms by mechanical stress, humidity, and thermal stress

Hydrate

Stable polymorph (API)

Intramolecular H-bonding

Page 6: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

4 6 8 10 12 14 16 18 20 22

2Theta

Physical transformation by Mechanical Stress

Form II

Form III

Milled Gabapentin

Page 7: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Physical transformation by Humidity

2theta

7

Inte

nsity

47 hrs in 40C 31 %RH29 hrs17 hrs 7 hrs 0 hr

Page 8: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Physical transformation by Thermal Stress

Kaushal and Suryanarayanan., Minnesota Univ. AAPS poster 20098

Page 9: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Chemical Degradation of Gabapentin– nucleophilic attack of nitrogen on carbonyl

ONH

Gabapentin Gabapentin _lactam

9

toxicUSP limit: < 0.4%

Page 10: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Aqueous degradation kinetics

OOH

NH2 NH

O

gabapentin lactam

Irreversible cyclization

+ H2O

Page 11: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Solid state degradation kinetics40 C 5% RH, milled gabapentin

0

1

2

3

4

5

6

7

0 100 200 300 400 500 600

Lact

am (m

ole

%)

hours

initial lactamrapid degradation of process-damaged gaba

autocatalytic lactam formation

Page 12: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

12

Solid state Degradation Model

GABA (G)(stable form) LACTAM (L)

autocatalytic branching

spontaneous dehydration

branching termination

LDGk 1

Dk2GABA (D)(unstable form)

DGk3

Hypothesis:Manufacturing stress determines initial conditions (G0, D0 and L0)Environmental (storage) stress determines kinetics (k1, k2 and k3)

Page 13: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Building a quantitative model

13

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 14: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

14

Effects of Manufacturing Stress:Initial Lactam and Instability

0 5 10 15 20 25 300.0

0.5

1.0

1.5

2.0

2.5%

lact

am

time(days)

60 min milled

45 min milled

15 min milled

API as received

Thermal stressed at 50 °C, 5%RH

Lactam generated during milling(in-process lactam)

Milling caused faster degradation rate

Page 15: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

15

Effects of Milling Stress:Specific Surface Area

0 20 40 600

4

8

12

16

20Su

rface

Are

a(m

2 /g)

Milling Time (min)

Is the increase of lactamization rate solely due to increase of Surface Area?

Page 16: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

16

Can Surface Area account for Lactamization Rate Changes upon

Mechanical Stess?

0 5 10 15 200

0.2

0.4

0.6

0.8

1

Specific Surface Area(m2/g)

Lact

amiza

tion

Rate

(mol

e%/d

ay 5

0 °C

)

Samples milled for different time

Sieved aliquots of 15min milled sample

Sieved aliquots of unmilled sample

NO, ALSO increased regions of crystal disorder caused by the mechanical stress.

Page 17: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effects of Milling based on Change in Initial Condition: lactam formation (50 °C)

17

TreatmentD0(%)

k1*104

(%mole-1hr-1)k2

(hr-1)

unstressed 0.02

0.6 0.017

15min milled 0.5945min milled 1.2860min milled 1.62

Lact

am m

ole

%

Time (hr)

60min mill

45min mill

15min mill

unstressed0

0.5

1

1.5

2

2.5

3

3.5

0 200 400 600 800 1000 1200 1400

milling time effect

Page 18: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effects of Environmental Stress: temperature and humidity

18

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 19: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Lactam kinetics under controlled temperature (40-60 C) and humidity (5-50% RH)

0

5

10

15

20

0 100 200 300 400 500 600 700 800

Lact

am (%

mol

e)

Hours

Page 20: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effects of Temperature:predicted values based on parameterization of

autocatalytic model

0 50 100 150 200 2500

5

10

15

20

25

time(hours)

Lact

am m

ole%

Gaba 40C 5%RH

Gaba 50C 5%RHGaba 60C 5%RH

Page 21: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

21

Effects of Moisture

Page 22: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Is the decreased lactam rate due to reversible reaction?

• Thermal stress of solid state (milled) or aqueous gabapentin_lactam– No detectable loss of lactam and no appearance

of gabapentin in solution and solid state

Zong et.al., Draft submitted to AAPS Pharm Sci Tech. 2010

COOHNH2

ONH

Gabapentin Gabapentin_lactam

+H20

22

Page 23: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

23

Why moisture appears to slow and shut down lactam formation?

• In general, effect of moisture is NOT to slow reaction rates

• Analytical issue?

• Reversible reaction?

• Formation of stable hydrate?No gabapentin formed from gaba-L in solution or solid state

No hydrate found from XRD patterns

Most gaba-L could be recovered from solid powder, only ignorable gaba-L was detected in saturated salt solution.

Moisture-facilitated termination of branching

Page 24: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

24

Effect of Moisture:Shut down Lactam Formation

0

1

2

3

4

0 20 40 60 80 100

Gaba

-L C

once

ntra

tion

(Mol

e %

)

Hours

Pretreated at 5% RH 25°C for 24 hours before thermal stress

Pretreated at 81% RH 25°C for 24 hours before thermal stress

Thermal stress: 50°C 5%RH

Page 25: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

k1 (%mole-1hr-1)

k2 (hr-1)

D0 (%)

L0 (% mole)

0.000021 0.0074 1.05 0.37k3(%mole-1hr-1)

5%RH 11%RH 30%RH 50%RH

�0 0.014 0.030 0.099

Effects of Moisture

40 C 50%RH

40 C 30%RH

40 C 5%RH

25

Lact

am m

ole

%

Time (hr)

40 C 11%RH

0

1

2

3

4

5

0 100 200 300 400 500

moisture effect gaba simulation

Page 26: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effects of Compositional Factors: excipient effects

26

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 27: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Excipient EffectsComparison of lactam formation kinetics between neet gabapentin

and gabapentin/HPCcontrolled temperature (40-60 C) and humidity (5-50% RH)

0

10

20

30

40

50

60

0 100 200 300 400 500 600 700 800

Lact

am (%

mol

e)

Hours

Gabapentin

0

10

20

30

40

50

60

0 100 200 300 400 500 600 700 800

Lact

am (%

mol

e)

Hours

Gabapentin & 6.5% HPC

Page 28: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

– Mixtures of gabapentin & excipients– Co-milled– Storage conditions: 5 to 50% RH at 50 ˚C

• Excipients (50% w/w)– CaHPO4.2H20 (Emcompress)– Corn starch– Microcrystalline cellulose (Avicel PH101)– HPMC 4000– Colloidal SiO2 (Cab-O-Sil)– Talc (Mg silicate)– HPC (6.5% w/w)

Evaluation of the role of excipients in gabapentin SS degradation

Saturated solution 50˚C

0

10

20

30

40

50

0 100 200 300 400 500

5RH 4:47:40 AM 10/22/2010

gabaAviHPMCCabTalcHPC Calccorngaba obscalc obscorn obsAvi obsHPMC obsCab obsTalc obsHPC obs

Gaba

Starch

CaHPO4SiO2

HPC AvicelHPMC

Talc

Lact

am m

ole

%Time (hr)

Page 29: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Model parameterization usingexcipient-induced variation in crystal damage during

milling and termination rate

0

10

20

30

40

50

0 100 200 300 400 500

Lact

am (%

mol

e)

Hours

SiO2

CaHPO4

Starch

MCC

HPMC

Talc

HPC (6.5%)

Excipient k1 k2 k3104 D0 (%)SiO2 0.0

00074

0.016

5.55 21.1

CaHPO4 2.37 10.6

Starch 2.62 4.5

MCC 7.80 7.2

Talc 1.35 8.4

HPMC 1.20 7.4

HPC (6.5%) 4.04 6.5

Excipient effects• Crystal damage (D0) during milling• Kinetics of branching and termination(k3)

Page 30: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effect of Excipients based on Change in Initial Conditions and Rate Constants: under low humidity

30

k1 *104

(%mole-1hr-1) k2(hr-1)

D0 (%)

L0 (% mole)

SiO2 0.27 0.0208 21.16 2.6Talc 0.33 0.0116 8.44 0.98Starch 0.35 0.0150 4.54 0.30HPMC 0.41 0.0123 7.42 0.30Avicel 0.49 0.0148 7.21 0.26

HPC (6.5%) 0.55 0.0209 6.52 0.30Gaba 0.74 0.0149 1.05 0.37

Page 31: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Effect of Excipients based on Change in Rate Constants: under low humidity

31

k1(%mole-1hr-1)

k2(hr-1)

k3*102

(%mole-1hr-1) D0 (%)

L0 (% mole)

HPMC

0.000074 0.016

0.012 7.42 0.30Talc 0.014 8.44 0.98

CaHPO4 0.023 10.6 0.60

HPC (6.5%) 0.041 6.52 0.30SiO2 0.056 21.1 2.60Avicel 0.078 7.21 0.26Starch 0.260 4.54 0.30Gaba 30 1.05 0.37

Page 32: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Moisture and excipient effectsNo excipient Co-milled excipient (SiO2)

5 %RH 11 %RH30 %RH

50 %RH

11 %RH

30 %RH

50 %RH

5 %RH

32

0

10

20

30

40

50

0 100 200 300 400 500 600

Data 10

BDFH

Lact

am m

ole

%

Time (hr)

0

5

10

15

20

0 100 200 300 400 500 600 700 800

moisture effect gaba50RH

0RH11RH30RH50RH

Page 33: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Linking Stability in Design SpaceManuf.Design SpaceModel

L0D0

Post-Manuf.

Degradation

Model

LtEndof

Expiry

• Key Research Findings• Manufacturing Stress impacts drug stability upon storage:

L0 (in-process lactam) D0 (unstable gabapentin)

• Predictive model for drug stability includes:• Environment factor: temperature () & humidity ()• Compositional factors: both kinetic and initial condition

effects• Manufacturing factors: L0 and D0

• Model validation: completion of long term stability

Page 34: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Measuring the manufacturing stress effects• Physical methods

– Raj Suryanarayanan (University of Minnesota) – Eric Munson (University of Kentucky)

• Chemical and kinetic measurements– Lee Kirsch (University of Iowa

Solid State NMR KansasRaman spectroscopy MinnesotaPowder x-ray diffraction (XRD) MinnesotaDSC/TGA All Water vapor sorption MinnesotaHPLC Iowa

Page 35: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Chromatographic methods

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0.00

0.25

0.50

0.75

1.00

1.25

1.50

mAU

0.00

0.25

0.50

0.75

1.00

1.25

1.50

4093

741

Gab

apen

tin

3.65

8

2388

5.39

0

4339

La

ctam

7.28

8

3853

9.11

7

Detector 1-210nmhydBt0H

AreaNameRetention Time

Detector 1-210nmhydBt24H

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.004%.

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0

1

2

3

4

mAU

0

1

2

3

4

2801

635

Gab

apen

tin

3.66

8

8278

La

ctam

7.30

7

Detector 1-210nmhydAt0H

AreaNameRetention Time

Detector 1-210nmhydAt24H

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.059%.

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0

5

10

15

20

mAU

0

5

10

15

20

4635

741

Gab

apen

tin

3.61

8

2878

43

7.57

2

(Lactam)

Detector 1-210nmlotAH

AreaNameRetention Time

Detector 1-210nmlotAHbefore

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.174%.

Page 36: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Manufacturing-stability measurements

• In process lactam (L0)– Change in lactam levels during specific treatment or unit

operation in % lactam/gabapentin on molar basis• Initial Rate of Lactam Formation (V0 or STS)

– Daily rate of lactam formation upon thermal stress at 50°C under low humidity

• D0 from Chemical Analysis

dayCk

kVD

DkV

o %/37.0)50(2

2

00

020

Page 37: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Insert Sury

Page 38: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Insert Eric

Page 39: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin

Applied Manufacturing-stability Measurements to Design Space and Risk Assessment

• Laboratory scale stability design space• Pilot scale stability design space• Risk assessment using Manufacturing-

stability Measurements